Skip to content
Home/Companies/Biotech/Molecule
Molecule

Molecule

Biotech·Germany·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Molecule?

Molecule is currently owned by BACKED VC through Backed Fund II (2022 vintage), since 2021. Across its history, Molecule has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-05-27

BACKED VC
Most recent investor
BACKED VC
Backed Fund II · 2022 · VC
3 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusActive
Websitewww.molecule.xyz

Ownership history

3 ownership periods · co-invest detected

Active
Co-held by Signature Ventures, Lunar Ventures and BACKED VC since 2020.
Co-invest · 3 holders · 2020 · present
Signature Ventures
Signature VenturesActive
2020 · present(6yr) · Signature Ventures Fund I · 2020 · VC
Lunar Ventures
Lunar VenturesActive
2020 · present(6yr) · Lunar Ventures Fund I · 2021 · VC
BACKED VC
BACKED VCActive
2021 · present(5yr) · Backed Fund II · 2022 · VC

More from Backed Fund II

Other portfolio companies in the same fund.

Auctor
Auctor
Active
FintechSingapore· 2022
BCB Group
BCB Group
Active
FintechUK· 2022
CoSyne Therapeutics
CoSyne Therapeutics
Active
BiotechUK· 2022
Footium
Footium
Active
GamingUK· 2022
Laguna Games
Laguna Games
Active
GamingUSA· 2022
Onramper
Onramper
Active
FintechNetherlands· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Molecule

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Molecule.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue